HGP – Marathon Asset Management Announces Acquisition of Kaléo
January 24, 2022 | Read more >
kaleo
HGP – Kaléo Announces ALLERJECT® Auto-Injector Will Be Available for Canadians at Risk for Anaphylaxis
May 12, 2020 | Read more >
HGP – Richmond-based Kaléo Makes Deal with Walgreens to Stock Allergic Reaction Injector for Infants and Toddlers
July 12, 2019 | Read more >
HGP – Walgreens and Kaléo Partner to Address Epinephrine Auto-Injector Supply Issues
October 13, 2018 | Read more >
HGP – AUVI-Q® (epinephrine injection, USP) Available in Canada Starting September 7
October 11, 2018 | Read more >
HGP – With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)
April 26, 2018 | Read more >